Ana Rita Nobre

7PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
CXCL1-CXCR2 signaling mediates cancer cell growth and response to radiation therapy in leptomeningeal metastasis.

|Mar 10, 2025
Autocrine CXCL1-CXCR2 Signaling Mediates Leptomeningeal Resistance to Radiation Therapy.

Ahmed M Osman, Jan Remsik, Jenna Snyder

|Oct 28, 2024
Retinoid X Receptor Signaling Mediates Cancer Cell Lipid Metabolism in the Leptomeninges.

Xinran Tong, Jan Remsik, Jeanette Brook

|Nov 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.

Veronica Calvo, Wei Zheng, Anna Adam-Artigues

|Sep 01, 2022
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.

Ana Rita Nobre, Erica Dalla, Jihong Yang

|Nov 23, 2021
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy.

Bassem D Khalil, Roberto Sanchez, Tasrina Rahman

Pageof 2

Frequent Collaborators

4 joint publications

Adrienne Boire

3 joint publications

Jan Remsik

3 joint publications

Sofia Piedrafita-Ortiz

3 joint publications

Jenna Snyder